TMCnet News
Research and Markets: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/2gzmns/u_s_market_for) has announced the addition of the "U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014" report to their offering. According to the Center for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death among Americans as of 2014. Moreover, diagnosed diabetes had an estimated cost of over $245 billion in the U.S. in 2013. The prevalence of the disease led to a market size for diabetes monitoring, treatment and drug delivery of over $16.7 billion. This market will grow in conjunction with the number of diagnosed diabetics. Some segments will grow faster than others as the demand for moder and more efficient products is increasing faster than the rate of new diabetics. Conversely, reimbursement cuts and declining prices in some segments will affect the market negatively. Scope of report: This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. Market.
Key Topics Covered: TABLE of CONTENTS EXECUTIVE SUMMARY U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY market TRADITIONAL BLOOD GLUCOSE METER MARKET LANCET AND LANCING DEVICE MARKET CONTINUOUS GLUCOSE MONITORING MARKET INSULIN PUMP MARKET MODERN INSULIN MARKET INSULIN SYRINGE MARKET MODERN INSULIN PEN MARKET ABBREVIATIONS Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/2gzmns/u_s_market_for |
